Luigi Buonaguro
Luigi Buonaguro
National Cancer Institute Pascale, Naples IT
Email verificata su
Citata da
Citata da
Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation.
B Ensoli, L Buonaguro, G Barillari, V Fiorelli, R Gendelman, RA Morgan, ...
Journal of virology 67 (1), 277-287, 1993
HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region
HC Chang, F Samaniego, BC Nair, L Buonaguro, B Ensoli
Aids 11 (12), 1421-1431, 1997
Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications
L Buonaguro, ML Tornesello, FM Buonaguro
Journal of virology 81 (19), 10209-10219, 2007
Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines.
L Buonaguro, G Barillari, HK Chang, CA Bohan, V Kao, R Morgan, ...
Journal of virology 66 (12), 7159-7167, 1992
Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis.
G Barillari, L Buonaguro, V Fiorelli, J Hoffman, F Michaels, RC Gallo, ...
The Journal of Immunology 149 (11), 3727-3734, 1992
Translating tumor antigens into cancer vaccines
L Buonaguro, A Petrizzo, ML Tornesello, FM Buonaguro
Clin. Vaccine Immunol. 18 (1), 23-34, 2011
The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure.
L Buonaguro, FM Buonaguro, G Giraldo, B Ensoli
Journal of virology 68 (4), 2677-2682, 1994
Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses
L Buonaguro, ML Tornesello, M Tagliamonte, RC Gallo, LX Wang, ...
Journal of virology 80 (18), 9134-9143, 2006
Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro
CA Bohan, F Kashanchi, B Ensoli, L Buonaguro, KA Boris-Lawrie, ...
Gene Expression The Journal of Liver Research 2 (4), 391-407, 1992
Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer
ML Tornesello, L Buonaguro, P Giorgi-Rossi, FM Buonaguro
BioMed research international 2013, 2013
Update on head and neck cancer: current knowledge on epidemiology, risk factors, molecular features and novel therapies
F Pezzuto, L Buonaguro, F Caponigro, F Ionna, N Starita, C Annunziata, ...
Oncology 89 (3), 125-136, 2015
Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections
ML Tornesello, L Buonaguro, F Tatangelo, G Botti, F Izzo, FM Buonaguro
Genomics 102 (2), 74-83, 2013
Antigen-specific vaccines for cancer treatment
M Tagliamonte, A Petrizzo, ML Tornesello, FM Buonaguro, L Buonaguro
Human vaccines & immunotherapeutics 10 (11), 3332-3346, 2014
High-level expression of the HIV-1 Pr55gag polyprotein in transgenic tobacco chloroplasts
N Scotti, F Alagna, E Ferraiolo, G Formisano, L Sannino, L Buonaguro, ...
Planta 229 (5), 1109-1122, 2009
Analysis of human papillomavirus type‐16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer
ML Tornesello, ML Duraturo, I Salatiello, L Buonaguro, S Losito, G Botti, ...
Journal of medical virology 74 (1), 117-126, 2004
High efficient production of Pr55gag Virus-like Particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A
L Buonaguro, FM Buonaguro, ML Tornesello, D Mantas, E Beth-Giraldo, ...
Antiviral research 49 (1), 35-47, 2001
Role of infectious agents in the carcinogenesis of brain and head and neck cancers
K Alibek, A Kakpenova, Y Baiken
Infectious agents and cancer 8 (1), 7, 2013
Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix
ML Tornesello, S Losito, G Benincasa, F Fulciniti, G Botti, S Greggi, ...
Gynecologic oncology 121 (1), 32-42, 2011
Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles …
L Buonaguro, ML Visciano, ML Tornesello, M Tagliamonte, B Biryahwaho, ...
Journal of virology 79 (11), 7059-7067, 2005
Immunogenomics and systems biology of vaccines
L Buonaguro, B Pulendran
Immunological reviews 239 (1), 197-208, 2011
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20